Literature DB >> 1816320

Macrophage-derived factors increase low density lipoprotein uptake and receptor number in cultured human liver cells.

R I Grove1, C Mazzucco, N Allegretto, P A Kiener, G Spitalny, S F Radka, M Shoyab, M Antonaccio, G A Warr.   

Abstract

Recent evidence suggests the possibility that macrophages can influence lipoprotein metabolism. Therefore we investigated the ability of cultured macrophages to alter low density lipoprotein (LDL) uptake in a human liver cell line (HepG2). Conditioned media from phlogogenic-induced mouse peritoneal macrophages or from a human macrophage cell line stimulated with endotoxin increased HepG2 LDL uptake by as much as 60-70%. The increase was due, in part, to a significant macrophage-induced 40% increase in the number of LDL receptors per cell. Although macrophage conditioned media inhibited HepG2 cholesterol synthesis, the LDL receptor up-regulation did not appear to be due to the effects on cholesterol synthesis. The LDL receptor stimulatory activity was sensitive to proteolysis and heat. Its molecular mass was approximately 20 kDa based on gel filtration. Several macrophage secretory proteins were tested in HepG2 cultures for LDL uptake stimulation. Of these, oncostatin M (approximately 18 kDa by gel filtration) gave the strongest response. The rank order for LDL uptake stimulation was oncostatin M much greater than interleukin 6 = interleukin 1 = transforming growth factor-beta 1. A neutralizing antibody directed against oncostatin M inhibited the ability of conditioned media to up-regulate LDL receptors by 85%. Thus, our results indicate that macrophages can secrete several proteins that up-regulate LDL receptors in HepG2 cells and that most of the up-regulatory activity in macrophage conditioned media appears to be due to oncostatin M.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1816320

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  7 in total

Review 1.  The barrier hypothesis and Oncostatin M: Restoration of epithelial barrier function as a novel therapeutic strategy for the treatment of type 2 inflammatory disease.

Authors:  Kathryn L Pothoven; Robert P Schleimer
Journal:  Tissue Barriers       Date:  2017-06-13

2.  Oncostatin M is a mitogen for rabbit vascular smooth muscle cells.

Authors:  R I Grove; C Eberhardt; S Abid; C Mazzucco; J Liu; P Kiener; G Todaro; M Shoyab
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-01       Impact factor: 11.205

3.  Increased hepatic cholesterol accumulation in transgenic mice overexpressing human secretory phospholipase A2 group IIA.

Authors:  Rolf Eckey; Mario Menschikowski; Peter Lattke; Werner Jaross
Journal:  Inflammation       Date:  2004-04       Impact factor: 4.092

4.  Stimulation of low-density lipoprotein uptake in HepG2 cells by epidermal growth factor via a tyrosine kinase-dependent, but protein kinase C-independent, mechanism.

Authors:  A Graham; L J Russell
Journal:  Biochem J       Date:  1994-03-15       Impact factor: 3.857

5.  Endotoxin suppresses rat hepatic low-density lipoprotein receptor expression.

Authors:  W Liao; M Rudling; B Angelin
Journal:  Biochem J       Date:  1996-02-01       Impact factor: 3.857

6.  Upregulation of low density lipoprotein receptor activity by tumor necrosis factor, a process independent of tumor necrosis factor-induced lipid synthesis and secretion.

Authors:  W Liao; C H Florén
Journal:  Lipids       Date:  1994-10       Impact factor: 1.880

7.  Acute Myelogenous Leukemia Cells Secrete Factors that Stimulate Cellular LDL Uptake via Autocrine and Paracrine Mechanisms.

Authors:  Hasanuzzaman Bhuiyan; Michèle Masquelier; Loukas Tatidis; Astrid Gruber; Christer Paul; Sigurd Vitols
Journal:  Lipids       Date:  2017-05-09       Impact factor: 1.880

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.